Skip to main content

Table 1 Randomized controlled trials of selective decontamination of the digestive tract (SDD)a,b

From: Antibiotics or probiotics as preventive measures against ventilator-associated pneumonia: a literature review

Author

n

VAP incidence (versus control) - %

P-value

Mortality (versus control) - %

P-value

Kerver [13]

96

12 vs. 85%

< 0.001

29 vs. 32%

NS

Ledingham [14]

324

2 vs. 11%

0.006

24 vs. 24%

NS

Ulrich [15]

100

15 vs. 50%

< 0.001

31 vs. 54%

< 0.02

Aerdts [16]

88

0 vs. 26%

0.0001

12 vs. 15%

NS

Blair [17]

331

7 vs. 26%

0.002

15 vs. 19%

NS

Hartenauer [18]

200

10 vs. 45%

< 0.01

31 vs. 36%

NS

Gastinne [19]

445

12 vs. 15%

NS

34 vs. 30%

NS

Cockerill [20]

150

4 vs. 5%

NS

11 vs. 19%

NS

Hammond [21]

322

7 vs. 6%

NS

12 vs. 12%

NS

Jacobs [22]

91

0 vs. 9%

NS

39 vs. 54%

NS

Rocha [23]

101

15 vs. 46%

< 0.001

21 vs. 44%

< 0.05

Winter [24]

183

3 vs. 18%

< 0.05

36 vs. 43%

NS

Ferrer [25]

80

18 vs. 24%

NS

31 vs. 27%

NS

Palomar [26]

83

17 vs. 50%

0.005

24 vs. 31%

NS

Verwaest [27]

660

9 vs. 18%

0.026

18 vs. 17%

NS

Sánchez-García [28]

271

11 vs. 29%

< 0.001

39 vs. 47%

NS

Krueger [29]

546

2 vs. 11%

0.007

20 vs. 29%

NS

  1. aTrials reporting incidence rates of pneumonia. bAdministration of non-absorbable antibiotics in the mouth and the intestines, combined with a short course of systemic antibiotics. VAP, ventilator-associated pneumonia; NS, not significant; -, no data available.